Nothing Special   »   [go: up one dir, main page]

KR850001185A - 프로판-2-올 유도체의 제조방법 - Google Patents

프로판-2-올 유도체의 제조방법 Download PDF

Info

Publication number
KR850001185A
KR850001185A KR1019840004048A KR840004048A KR850001185A KR 850001185 A KR850001185 A KR 850001185A KR 1019840004048 A KR1019840004048 A KR 1019840004048A KR 840004048 A KR840004048 A KR 840004048A KR 850001185 A KR850001185 A KR 850001185A
Authority
KR
South Korea
Prior art keywords
propan
derivative
general formula
producing
preparing
Prior art date
Application number
KR1019840004048A
Other languages
English (en)
Inventor
쉬카네더(외 5) 헬뭇
Original Assignee
원본미기재
루드빅 호이만 운트 콤파니 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 루드빅 호이만 운트 콤파니 게엠베하 filed Critical 원본미기재
Publication of KR850001185A publication Critical patent/KR850001185A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음

Description

프로판-2-올 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 필요에 따라 생리적으로 받아들일 수 있는 염으로 전환되는 일반식(I)의 프로판-2-올 유도체의 제조방법에 있어서, 일반식(II)의 프로판-2-올 아민을 일반식(III)의 디아디아졸 유도체와 반응시켜 일반식(V)의 프로판-2-올 유도체를 형성시킨 후, 얻어진 일반식(V)의 프로판-2-올 유도체를 알코올성 암모니아 수용액과 반응시켜 일반식(I)의 화합물을 형성시킴을 특징으로하는 프로판-2-올 유도체의 제조방법.
    (이 식에서 R은
  2. 필요에 따라 생리적으로 받아들일 수 있는 염으로 전환되는 일반식(I)의 프로판-2-올 유도체의 제조방법에 있어서, 일반식(II)의 프로판-2-올 아민을 일반식(IV)의 시클로부텐디온 유도체와 반응시켜 일반식(VI)의 프로판-2-올 유도체를 형성시킨 후, 얻어진 일반식(VI)의 프로판-2-올 유도체를 알코올성 암모니아 수용액과 반응시켜 일반식(I)의 화합물을 형성시킴을 특징으로하는 프로판-2-올 유도체의 제조방법.
    (이 식에서 R은
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840004048A 1983-07-22 1984-07-11 프로판-2-올 유도체의 제조방법 KR850001185A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833326545 DE3326545A1 (de) 1983-07-22 1983-07-22 Propan-2-ol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DEP3326545.3 1983-07-22

Publications (1)

Publication Number Publication Date
KR850001185A true KR850001185A (ko) 1985-03-16

Family

ID=6204708

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840004048A KR850001185A (ko) 1983-07-22 1984-07-11 프로판-2-올 유도체의 제조방법

Country Status (16)

Country Link
US (1) US4599346A (ko)
EP (1) EP0132541A3 (ko)
JP (1) JPS6042375A (ko)
KR (1) KR850001185A (ko)
AR (1) AR242380A1 (ko)
AU (1) AU560038B2 (ko)
DE (1) DE3326545A1 (ko)
DK (1) DK290584A (ko)
ES (1) ES8504160A1 (ko)
GR (1) GR82256B (ko)
HU (1) HU192038B (ko)
IL (1) IL72179A0 (ko)
NZ (1) NZ208968A (ko)
PT (1) PT78923B (ko)
YU (1) YU123084A (ko)
ZA (1) ZA844651B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR033779A1 (es) * 2001-06-08 2004-01-07 Astrazeneca Ab Compuestos utiles en la enfermedad de reflujo
ATE420085T1 (de) 2002-09-25 2009-01-15 Daiso Co Ltd Verfahren zur herstellung von glycidylphthalimide
AU2003272967A1 (en) * 2002-10-28 2004-05-13 Kaneka Corporation Processes for producing optically active n-(2,3-epoxypropan-1-yl)phthalimide
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
US4390701A (en) * 1981-05-18 1983-06-28 Bristol-Myers Company 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
DE3275291D1 (en) * 1981-07-24 1987-03-05 Glaxo Group Ltd Heterocyclic derivatives
US4411899A (en) * 1981-12-21 1983-10-25 Merck & Co., Inc. Substituted derivatives of amino alkane diols as gastric secretion inhibitors
FR2532937A1 (fr) * 1982-07-08 1984-03-16 Glaxo Group Ltd Nouveaux derives de thiadiazolyl-s-oxyde, procede pour leur preparation et compositions pharmaceutiques les comportant
FI832520L (fi) * 1982-07-12 1984-01-13 Bristol Myers Co Farmaceutiska foerfaranden och sammansaettningar
US4521625A (en) * 1982-10-02 1985-06-04 Smith Kline & French Laboratories Limited Dioxocyclobutene compounds

Also Published As

Publication number Publication date
DK290584A (da) 1985-01-23
DK290584D0 (da) 1984-06-13
ZA844651B (en) 1986-02-26
EP0132541A2 (de) 1985-02-13
DE3326545A1 (de) 1985-01-31
US4599346A (en) 1986-07-08
AU2953684A (en) 1985-01-24
HU192038B (en) 1987-04-28
ES534479A0 (es) 1985-04-16
AR242380A1 (es) 1993-03-31
NZ208968A (en) 1986-11-12
PT78923A (de) 1984-08-01
AU560038B2 (en) 1987-03-26
GR82256B (ko) 1984-12-13
HUT34964A (en) 1985-05-28
JPS6042375A (ja) 1985-03-06
IL72179A0 (en) 1984-10-31
YU123084A (en) 1986-10-31
PT78923B (de) 1986-06-02
EP0132541A3 (de) 1985-09-25
ES8504160A1 (es) 1985-04-16

Similar Documents

Publication Publication Date Title
KR840005083A (ko) 항고혈압제로서 유용한 아미노산유도체의 제조방법
KR850006386A (ko) 아졸류의 제조방법
KR910021366A (ko) 4-(4-알콕시페닐)-2-부틸아민 유도체 및 그의 제조방법
KR830009084A (ko) 퀴놀린 카복실산 유도체의 제조방법
KR850006415A (ko) 항균제의 제조방법
KR860004025A (ko) 퀴놀론 카복실산의 제조방법
KR830000214A (ko) 펩타이드 유도체의 제법
KR850001185A (ko) 프로판-2-올 유도체의 제조방법
KR830005325A (ko) 수용성 화학 발광 시스템
KR840005146A (ko) N-(2-메톡시에틸)-노르옥시모르폰의 제조방법
KR840006230A (ko) 1-페닐-2-메틸-3-(1-피로리디닐)-1-프로판온 유도체의 제조방법
KR830005191A (ko) 푸란유도체의 제조방법
KR840004103A (ko) 디아졸릴 알칸올의 제조방법
KR830009077A (ko) 푸란 유도체의 제조방법
KR850005830A (ko) 2-알콕시아미노설포닐벤젠-설포닐우레아의 제조방법
KR840008335A (ko) 살충제의 제조방법
KR960022533A (ko) 리파마이신 유도체의 제조방법
KR830001890A (ko) 카바졸 유도체의 제조방법
KR880000411A (ko) 벤조구아나민 유도체의 제법
KR860004021A (ko) 에틸렌이민 유도체의 제조방법
KR840004720A (ko) 살충제 조성물 및 이의 제조방법
KR860004074A (ko) N-포스포노 메틸 글리신 염의 제조방법
KR840006477A (ko) 안식향산 유도체의 제조법
KR860004008A (ko) 부타놀유도체의 제법
KR850008662A (ko) 치환 안식향산 유도체의 제조방법

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19840711

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid